IL17A and psoriasis: Although a recent study reported that the compound worenine attenuated psoriasis inflammation in psoriatic model mice by inhibiting TOPK activity and that TOPK may affect IL-17 signaling pathway in phosphoproteomic analysis [26], the detailed mechanism by which TOPK contributes to psoriasis progression still needs further investigation.